89bio, Inc. (ETNB)
NASDAQ: ETNB · IEX Real-Time Price · USD
8.26
+0.01 (0.12%)
At close: Apr 26, 2024, 4:00 PM
8.33
+0.07 (0.85%)
After-hours: Apr 26, 2024, 7:26 PM EDT

89bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
772845592265484363
Market Cap Growth
-42.62%123.48%-45.28%33.64%-
Enterprise Value
221293425134280269
PE Ratio
-5.94-5.94-5.81-2.94-9.79-6.31
PB Ratio
1.441.583.902.112.394.03
P/FCF Ratio
-6.54-6.54-7.31-3.45-10.45-14.16
P/OCF Ratio
-6.54-6.54-7.31-3.45-10.48-14.24
EV/EBITDA Ratio
-2.20-2.20-4.25-1.49-5.65-4.71
EV/EBIT Ratio
-2.20-2.20-4.24-1.49-5.65-4.71
EV/FCF Ratio
-2.27-2.27-5.24-1.74-6.03-10.51
Debt / Equity Ratio
0.050.050.140.15--
Debt / EBITDA Ratio
-0.20-0.20-0.21-0.22--
Debt / FCF Ratio
-0.21-0.21-0.25-0.25--
Quick Ratio
19.5519.557.647.7225.2316.64
Current Ratio
20.0420.047.978.2925.9117.00
Interest Coverage
-27.85-27.85-52.07-132.93--
Return on Equity (ROE)
-31.00%-31.00%-83.70%-56.70%-34.90%-155.40%
Return on Assets (ROA)
-27.80%-27.80%-59.90%-50.70%-33.10%-107.40%
Return on Capital (ROIC)
-26.84%-26.84%-59.32%-61.74%-24.32%-29.62%
Earnings Yield
-18.41%-16.83%-17.22%-34.00%-10.22%-15.84%
FCF Yield
-16.73%-15.29%-13.69%-28.99%-9.57%-7.06%
Buyback Yield / Dilution
-104.48%-104.48%-73.18%-24.93%-586.28%-428.25%
Total Shareholder Return
-104.48%-104.48%-73.18%-24.93%-586.28%-428.25%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).